Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
22:08
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
FAQs
   
Discussion forum - BSH 2020 VIRTUAL
    Topic - Red Cell Disorders

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 146
Visits: 46
Title: One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Receiving Prior Eculizumab Treatment
Authors: Lindsay Mitchell , Austin Kulasekararaj, Lindsay Mitchell (presenter), Anita Hill, Saskia Langemeijer, Richard Wells, F. Ataúlfo González Fernández, Anna Gaya, Emilio Ojeda Gutiérrez, Caroline Piatek, Kensuke Usuki, Alberto Bosi, Robert Brodsky, Masayo Ogawa, Ji Yu, Stephan Ortiz, Alexander Rth, Jong Wook Lee, Regis Peffault de la Tour
Centre: 

You must be registered to reply or comment.

ONE-YEAR EFFICACY AND SAFETY FROM A PHASE 3 TRIAL OF RAVULIZUMAB IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA RECEIVING PRIOR ECULIZUMAB TREATMENT

Colin Griffin
Thread initiator
Subspeciality
Reg: 10/23/2020 1:38:00 PM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 11/9/2020 12:01:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 544
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre: 

Poster most viewed in this topic
Poster: 147
Visits: 106
Title: Assessment of longer-term efficacy, safety, and haematological improvement in the phase 3, randomised, double-blind, placebo-controlled MEDALIST trial of luspatercept to treat anaemia in patients with lower-risk myelodysplastic syndromes with ring sideroblasts who require red blood cell transfusions
Authors: Ghulam J. Mufti , o Ghulam J. Mufti, Paresh Vyas, Rena Buckstein, Valeria Santini, María Díez-Campelo, Carlo Finelli, Osman Ilhan, Mikkael A. Sekeres, Rami S. Komrokji, Amer M. Zeidan, Amit K. Verma, Abderrahmane Laadem, Peter G. Linde, Alan F. List, Uwe Platzbecker, Guillermo Garcia-Manero, Pierre Fenaux
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert